Financial Snapshot

Revenue
$162.5M
TTM
Gross Margin
35.89%
TTM
Net Earnings
-$166.4M
TTM
Current Assets
Q3 2023
Current Liabilities
Q3 2023
Current Ratio
273.19%
Q3 2023
Total Assets
Q3 2023
Total Liabilities
Q3 2023
Book Value
-$50.57M
Q3 2023
Cash
Q3 2023
P/E
-0.03044
Jun 25, 2024 EST
Free Cash Flow
-$133.0M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $5.0669 Million

About NS Wind Down Co., Inc.

NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. The company is headquartered in Seattle, Washington and currently employs 703 full-time employees. The company went IPO on 2013-06-26. The company develops, manufactures, and markets technologies of biological materials for life science researchers in the fields of genomics and proteomics. Its product platforms include nCounter Analysis System (nCounter), CosMx Spatial Molecular Imager, AtoMx Spatial Informatics Platform, and GeoMx Digital Spatial Profiler (GeoMx DSP). Its nCounter is a multi-application, digital detection and counting system which directly profiles hundreds of molecules simultaneously, using optical barcoding chemistry. Its nCounter platform is based on automated instruments that prepare and analyze biological samples using reagents. GeoMx DSP is used to analyze selected regions of an intact biological sample without the need to break down the sample, enabling researchers to see how gene expression might vary across those regions. Its CosMx Spatial Molecular Imager is a spatial biology product platform.

Industry: Biological Products, (No Diagnostic Substances) Peers: Adaptive Biotechnologies Corp NEOGENOMICS INC Bionano Genomics, Inc. SomaLogic, Inc. Cytek Biosciences, Inc. MAXCYTE, INC. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Seer, Inc. Sotera Health Co THERMO FISHER SCIENTIFIC INC.